SELECTBIO is thrilled to announce the continuation of Academic Drug Discovery for 2017!
Owing to the success of the conference in 2015 and 2016, this will now form part of a larger, multi-track event, with Antibodies in Drug Discovery, Epigenetics in Drug Discovery and Stem Cells in Drug Discovery, all held at the Wellcome Genome Campus Conference Centre on Monday 6th and Tuesday 7 March 2017 in Cambridge, UK. Attendees will benefit from unrestricted access to all four conference tracks.
In recent years pharmaceutical companies have moved away from conducting early-stage preclinical research in-house and are instead partnering with academic institutions to pursue programmes around emerging targets. This has resulted in significant opportunities for academic-based drug discovery and development centres.
Attracting a global audience of researchers, group leaders, directors and heads of leading academic and open innovation drug discovery centres, this event will explore the current challenges and opportunities faced in academic drug discovery. Topics covered include Open Innovation, Successful Partnering Models for Academia and Industry, Fragment Based Drug Discovery, New Lead Identification, Lead Optimisation and Medicinal Chemistry.
If you work in drug discovery research you will benefit from the expert knowledge and insights provided by key opinion leaders who are successfully implementing collaborations between academia and industry.
SELECTBIO is offering a limited number of student bursaries at this event. Find out more